100% Quality Guarantee
PhD-Level Technical Support
Key Features

FITC Anti-Human CD193/CCR3 Antibody [5E8] (AGEL3402)

SKU AGEL3402
Product Type Antibody
Antibody Type Monoclonal Antibody
Applications FCM
Reactivity Human
Host Species Mouse
Isotype Mouse IgG2b, k
Clone [5E8]
Conjugation FITC
€107 - €450

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

FITC Anti-Human CD193/CCR3 Antibody [5E8]

The FITC Anti-Human CD193 (CCR3) Antibody (5E8) offered by AssayGenie is a highly specialized tool designed for researchers studying the CD193 (CCR3) protein, a cell surface receptor involved in inflammatory responses and allergic reactions. This antibody, optimized for use in flow cytometry and immunofluorescence applications, specifically targets the CD193 (CCR3) molecule in human samples with high accuracy and sensitivity.CD193 (CCR3) is a critical receptor implicated in allergic diseases, asthma, and inflammation, making it a key target for research in immunology and respiratory conditions. By using the FITC Anti-Human CD193 (CCR3) Antibody (5E8), researchers can effectively detect and analyze the expression and localization of CD193 (CCR3) in various cell types, providing valuable insights into its role in immune responses and disease pathogenesis.

With its superior specificity and performance in experimental settings, this antibody enables precise and reliable detection of CD193 (CCR3), facilitating detailed investigation into its signaling pathways and potential therapeutic implications. Researchers can leverage the unique capabilities of this antibody to advance their studies in allergy, asthma, and inflammatory disorders, ultimately contributing to the development of novel treatment strategies and improved patient outcomes.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose